focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 239.00
Bid: 235.00
Ask: 243.00
Change: 3.00 (1.27%)
Spread: 8.00 (3.404%)
Open: 236.00
High: 0.00
Low: 0.00
Prev. Close: 236.00
PCA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Buyback

15 Jun 2023 11:21

RNS Number : 8707C
Palace Capital PLC
15 June 2023
 

15 June 2023

Palace Capital plc

("Palace Capital" or the "Company")

Share Buyback

 

As announced in the Preliminary Results announcement this morning, Palace Capital is extending the share buyback programme (the 'Programme') announced on 6 February 2023 following the successful repurchase of shares under the previous Programmes.

 

The Company intends to repurchase up to a further 1,000,000 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") representing approximately 2.3% of the Company's Ordinary Shares in issue with voting rights. The aggregate purchase price of all Ordinary Shares acquired under the Programme will be no more than £2.5 million (excluding stamp duty and expenses) under the resolution passed at the 2022 AGM.

 

The Company has appointed Numis Securities Limited ("Numis") to manage the Programme.

Share purchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. Purchases of the Company's shares under the Programme will commence from today. The Programme is in accordance with the Company's general authority to purchase a maximum of 4,632,892 Ordinary Shares, granted by its shareholders at the Annual General Meeting held on 29 July 2022. The Programme will be effected within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (as in force in the UK from time to time, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019). The Company confirms that it currently has no other unpublished price sensitive information.

Share repurchases will be made on the Company's behalf and in accordance with the arrangement with Numis in open market transactions, depending on market conditions, share price and trading volume. The maximum price paid per ordinary share will be limited to be no more than the higher of (i) 105 per cent of the average middle market closing price of the Company's ordinary shares for the five business days before the purchase is made, and (ii) the higher of the price of the last independent trade and the highest current independent bid on the trading venue where the purchase is carried out. It is intended that repurchased shares will be held in treasury. Such treasury shares are not entitled to dividends and have no voting rights at the Company's general meetings.

Due to the limited liquidity in the Ordinary Shares, a buyback of Ordinary Shares pursuant to the Programme on any given trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the London Stock Exchange and may exceed 25 per cent of the average daily trading volume and, accordingly, the Company may not benefit from the exemption contained in Article 5(1) of Regulation (EU) No. 596/2014.

Palace Capital plc Steven Owen, Interim Executive Chairman / Matthew Simpson, Chief Financial Officer info@palacecapitalplc.com or via FTI

Financial PR FTI ConsultingDido Laurimore / Giles BarrieTel: +44 (0)20 3727 1000palacecapital@fticonsulting.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSNKPBDKBKDCAD
Date   Source Headline
14th Feb 20237:00 amRNSIndustrial property disposal
6th Feb 20237:00 amRNSShare Buyback
22nd Dec 20227:00 amRNSDisposals and Debt Position Update
25th Nov 20224:40 pmRNSSecond Price Monitoring Extn
25th Nov 20224:35 pmRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSInterim Results
20th Oct 202212:03 pmRNSDirector Dealing
18th Oct 20223:49 pmRNSHolding(s) in Company
12th Oct 20227:00 amRNSTrading Update
15th Sep 20227:00 amRNSDividend Declaration
18th Aug 20222:51 pmRNSDirector Dealing
12th Aug 20227:00 amRNSBoard change
2nd Aug 20227:00 amRNSBoard change
29th Jul 20223:18 pmRNSResult of AGM
28th Jul 20221:39 pmRNSHolding(s) in Company
20th Jul 20226:04 pmRNSDirector Dealing
19th Jul 20227:00 amRNSFurther Update on Strategy and Changes to Board
15th Jul 20224:27 pmRNSHolding(s) in Company
13th Jul 202211:58 amRNSHolding(s) in Company
12th Jul 20223:36 pmRNSHolding(s) in Company
12th Jul 20229:50 amRNSHolding(s) in Company
12th Jul 20227:00 amRNSTransaction in Own Shares
4th Jul 20227:01 amRNSCommencement of share buyback
4th Jul 20227:00 amRNSUpdate on Strategy
28th Jun 202210:27 amRNSAnnual Report and Notice of Annual General Meeting
14th Jun 20222:10 pmRNSDividend Declaration
14th Jun 20227:01 amRNSResults for the year ended 31 March 2022
14th Jun 20227:00 amRNSBoard Change
1st Jun 20225:04 pmRNSTotal Voting Rights
6th Apr 20227:00 amRNSTrading update and dividend increase
25th Mar 20229:10 amRNSHolding(s) in Company
16th Mar 20223:58 pmRNSHolding(s) in Company
15th Mar 20222:03 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Declaration and Market Update
14th Mar 20229:46 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPalace Capital exceeds disposal strategy targets
20th Jan 20224:40 pmRNSSecond Price Monitoring Extn
20th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSAcquisition of Maidenhead office building
20th Dec 20217:00 amRNSDisposal strategy nears completion
16th Dec 20217:00 amRNSAppointment of new Chairman
15th Dec 202110:46 amEQSHardman & Co Research: Hardman & Co Video | Analyst interview Q&A with Mike Foster on Palace Capital (PCA) | Interim results - ammunition for major dividend rises
9th Dec 20217:00 amRNSLetting of office space at Hudson Quarter, York
6th Dec 20217:00 amRNSSale of Staines Office Building
3rd Dec 202112:40 pmEQSHardman & Co Research : Palace Capital (PCA) - Interim results: ammunition for major dividend rises
29th Nov 20217:00 amRNSDisposal strategy continues with Aldershot sale
18th Nov 20217:00 amRNSDirector Dealing
17th Nov 20211:04 pmRNSINVESTOR PRESENTATION
16th Nov 20217:00 amRNSInterim Results
12th Nov 202110:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.